Brian K Law

Brian K Law, Ph.D.

Associate Professor

Department: MD-PHARMACOLOGY / THERAPEUTICS
Business Phone: (352) 273-9423
Business Email: bklaw@ufl.edu

Publications

2005 Critical Reviews in Oncology Hematology

Grants

Aug 2019 ACTIVE
Tranexamic Acid Activity Against Melanoma and Breast Cancer
MURDOCK TECHNOLOGIES · Principal Investigator
Jul 2019 ACTIVE
Dual mechanisms of DDA antitumor activity: Induction of tumor cell apoptosis and vascular disruption
FL BREAST CANCER FOU · Principal Investigator
Jul 2018 ACTIVE
A new approach for eradicating metastatic, drug-resistant breast cancers
OCALA ROYAL DAMES FOR CANCER RESEARCH · Principal Investigator
Feb 2018 – May 2019
Synthetic lethal strategy for killing EGFR+/HER2+ cancers
FL BREAST CANCER FOU · Principal Investigator
Jul 2015 ACTIVE
Florida Academic Cancer Center Alliance Seed Grants
UF HEALTH SHANDS HOSPITAL · Project Manager
Jun 2015 – Sep 2019
Novel agents that simultaneously downregulate Her2, EGFR, and Her3
US ARMY MED RES ACQUISITION · Principal Investigator
Feb 2015 ACTIVE
UF Health Cancer Center Pilot Project Grants funded through the Florida Consortium of National Cancer Institute Centers Program
UF HEALTH SHANDS HOSPITAL · Project Manager
Feb 2015 – Jan 2016
Triple Negative Breast Cancer
UF FOU · Principal Investigator
Sep 2014 – Mar 2018
Autophagy in liver injury
NATL INST OF HLTH NIDDK · Project Manager
Jul 2014 ACTIVE
Martens-Maren Chair Fund
UF FOU UNRESTRICTED DONATION · Project Manager
Dec 2013 – Nov 2015
Chemistry and Biology of Apratoxins
FL DEPT OF HLTH BANKHEAD-COLEY CANCER RE · Project Manager
Oct 2013 – Oct 2016
Nuovo Biologics Testing
NUOVO BIOLOGICS · Principal Investigator
Mar 2013 – Aug 2019
Novel Targeted Anticancer Agents from Marine Cyanobacteria
NATL INST OF HLTH NCI · Project Manager
Jul 2006 ACTIVE
21st Century Research & Economic Development Investment Program (REDIP)
STATE UNIV SYS OF FL BOARD OF GOVERNORS · Project Manager

Patents

Published February 2012
Methods and Compositions for the Treatment of Cancers and Pathogenic Infections
#US-2012-0141491-A1
Issued October 2013
Cyclin Dependent Kinase Inhibitors
#8,569,356
Issued November 2016
Combination Compositions and Methods of Treatment
#9,492,434
Published April 2017
Novel Small Molecule Anticancer Agents
#US-2017-0240570-A1

Contact Details

Phones:
Business:
(352) 273-9423
Emails:
Business:
bklaw@ufl.edu